People News: Alexion Pharmaceuticals and KV Pharmaceutical

Alexion Pharmaceuticals appointed William Keller to its board of directors, effective immediately, bringing to eight the number of members. Keller is founder and general manager of Keller Pharma Consultancy, based in China, and serves as a senior consultant to the Shanghai Foreign Investment Development Board, as well as deputy general manager of Zhangjiang Biotech & Pharmaceutical Base Development Co. From 1976 to 2003, he held various positions with Roche Group in Asia and South America.

Specialty firm KV Pharmaceutical named David Van Vliet CEO, with a term through December 31, 2011. Van Vliet has served as interim president and CEO since December 2008.
You must be a registered member of MMM to post a comment.

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.